Zevra Therapeutics GAAP EPS of -$1.30 misses by $0.12, revenue of $27.46M beats by $1.48M SeekingAlpha 28 Mar 2024
Stoke Therapeutics GAAP EPS of -$0.60 beats by $0.02, revenue of $2.8M misses by $0.42M SeekingAlpha 25 Mar 2024